Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora rand

Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora rand

Item
http://www.wikidata.org/entity/Q36086970
Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan AfricaMaternal CD4+ cell count decline after interruption of antiretroviral prophylaxis for the prevention of mother-to-child transmission of HIVMaternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after deliveryOutcomes in a cohort of women who discontinued maternal triple-antiretroviral regimens initially used to prevent mother-to-child transmission during pregnancy and breastfeeding--Kenya, 2003-2009Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysisEstimating PMTCT's Impact on Heterosexual HIV Transmission: A Mathematical Modeling AnalysisTransmission of Zika virus through breast milk and other breastfeeding-related bodily-fluids: A systematic reviewA Systematic Review of Interventions to Reduce Maternal Mortality among HIV-Infected Pregnant and Postpartum WomenMaternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.Vertical HIV transmission in perinatally-exposed infants in South-Rift region of Kenya: a retrospective cross sectional studyRetention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort studyThe special programme of research in human reproduction: forty years of activities to achieve reproductive health for all.Reproductive and maternal healthcare needs of HIV infected women.Adverse drug reactions associated with antiretroviral therapy during pregnancy.Editorial commentary: turning the tide on HIV in women and children: preventing breast-milk HIV transmission while increasing maternal life expectancy.The telomerase inhibitor AZT enhances differentiation and prevents overgrowth of human pluripotent stem cell derived neural progenitors.
P2860

Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora rand

Item
http://www.wikidata.org/entity/Q36086970
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Maternal HIV-1 disease progres ...... phylaxis): The Kesho Bora rand
@ast
Maternal HIV-1 disease progres ...... phylaxis): The Kesho Bora rand
@en
type
label
Maternal HIV-1 disease progres ...... phylaxis): The Kesho Bora rand
@ast
Maternal HIV-1 disease progres ...... phylaxis): The Kesho Bora rand
@en
prefLabel
Maternal HIV-1 disease progres ...... phylaxis): The Kesho Bora rand
@ast
Maternal HIV-1 disease progres ...... phylaxis): The Kesho Bora rand
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Maternal HIV-1 disease progres ...... phylaxis): The Kesho Bora rand
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932